Apellis Initiates Phase 1/2 Study of APL-9 in Patients with Severe COVID-19

The randomized, multi-center, controlled Phase 1/2 study is expected to enroll 66 hospitalized patients with COVID-19 and respiratory failure who require oxygen supplementation or mechanical ventilation.